EZZ delivers strong FY2022 cash flow result despite tough start
By Louis Allen EZZ Life Science (ASX: EZZ) has announced that despite a challenging start, it enjoyed a strong finish to the financial year ending June (FY2022) – placing it in a robust financial position for future growth. The genomic…